Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afc5d8c9ee6673323cee3e2d19bc5146 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
2000-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e93531f471b48b0dd18c2004517d68d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6663f5f3ae81d5dba18a09c8b196daa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2edc8f6131d7b8f34205d90442dafbf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ae4618a66b63cf206ffd3ce29c87350 |
publicationDate |
2000-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2373150-A1 |
titleOfInvention |
Method for diagnosis of alzheimer's disease |
abstract |
The present invention is directed to a method of diagnosing Alzheimer's disease involving analysis of a plasma or serum sample in such a way that .beta.-amyloid1-42 or A.beta.3pE is completely or nearly completely (ie., thoroughly) dissociated from binding proteins prior to the analysis of the levels of .beta.-amyloid1-42 or A.beta.3pE. |
priorityDate |
1999-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |